CVS Health Corporation (CVSD.XC)
| Previous close | 56.78 |
| Open | 56.78 |
| Bid | 54.19 x N/A |
| Ask | 54.36 x N/A |
| Day's range | 56.78 - 56.78 |
| 52-week range | 56.78 - 68.12 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 71.28B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | 10.67 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.49 (4.39%) |
| Ex-dividend date | 19 Apr 2024 |
| 1y target est | N/A |
- Investor's Business Daily
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.
- Bloomberg
Walgreens’ Shares Plunge on Outlook Cut, More Store Closings
(Bloomberg) -- Walgreens Boots Alliance Inc. slashed its guidance due to a worsening retail environment and announced it would close significantly more stores as its new chief executive officer seeks to turn the business around.Most Read from BloombergSupreme Court Poised to Allow Emergency Abortions in IdahoSpaceX Tender Offer Said to Value Company at Record $210 BillionBolivia’s President Arce Swears in New Army Chief After Coup BidChina’s Finance Elite Face $400,000 Pay Cap, Bonus ClawbacksSu
- Zacks
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
